FDA approves Medingo’s insulin pump
TEL AVIV, Israel An Israeli company can market its insulin pump in the United States, the Food and Drug Administration has determined.
The FDA gave marketing approval to the Solo MicroPump Insulin Delivery System, made by Elron Electronic Industries’ subsidiary Medingo, which the company will introduce next month at the American Association of Diabetes Educators’ meeting in Atlanta.
“We are very excited to have received FDA clearance for Medingo’s innovative, miniature, tube-free insulin delivery system,” Medingo and Elron chairman Arie Mientkavich said in a statement. “This is a major milestone for Medingo, which will enable it to progress to the next phase in its development.”